Voya Investment Management LLC Arcus Biosciences, Inc. Transaction History
Voya Investment Management LLC
- $71.9 Billion
- Q1 2025
A detailed history of Voya Investment Management LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 42,603 shares of RCUS stock, worth $380,870. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,603
Previous 24,674
72.66%
Holding current value
$380,870
Previous $367,000
8.99%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding RCUS
# of Institutions
201Shares Held
54.1MCall Options Held
304KPut Options Held
103K-
Black Rock Inc. New York, NY9.76MShares$87.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.69MShares$59.8 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA5.13MShares$45.8 Million0.28% of portfolio
-
State Street Corp Boston, MA3.7MShares$33 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.56MShares$22.9 Million0.88% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $645M
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...